Pays: Grèce
Langue: anglais
Source: HMA (Heads of Medicines Agencies)
atipamezole hydrochloride 5 mg
Eurovet Animal Health
QV03AB90
Solution for injection
atipamezole
Cats, Dogs
2008-12-02
Revised: June 2013 AN. 00690/2012 Page 1 of 5 _ _ SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Atipam, 5.0 mg/ml, solution for injection for cats and dogs. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active ingredients Atipamezole hydrochloride 5.0 mg (equivalent to 4.27 mg atipamezole base) Excipients Methyl parahydroxybenzoate (E 218) 1.0 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear and colourless sterile aqueous solution. 4. CLINICAL PARTICULARS 4.1. TARGET SPECIES Cats and dogs. 4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Atipamezole hydrochloride is a selective α2-antagonist and is indicated for reversal of the sedative effects of medetomidine and dexmedetomidine in cats and dogs. 4.3. CONTRAINDICATIONS The product should not be used in: - Breeding animals - Animals suffering from liver- or renal diseases See also section 4.7. 4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES Make sure the animal has regained a normal swallowing reflex before any food or drink is offered. 4.5. SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS After administration of the product, the animals should be allowed to rest in a quiet place. During recovery time animals should not be left unattended. Due to different dosing recommendations caution should be taken if using the product off-label in animals other than the target species. Revised: June 2013 AN. 00690/2012 Page 2 of 5 _ _ If sedatives other_ _than (dex)medetomidine are given, it must be kept in mind that the effects of thos Lire le document complet